The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArrow Explor. Regulatory News (AXL)

Share Price Information for Arrow Explor. (AXL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: -2.75 (-11.83%)
Spread: 1.00 (5.00%)
Open: 22.50
High: 22.50
Low: 20.50
Prev. Close: 23.25
AXL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

21 Sep 2023 07:00

RNS Number : 1374N
Arrow Exploration Corp.
21 September 2023
 

NOT FOR RELEASE, DISTRIBUTION, PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

ARROW ANNOUNCES AGM VOTING RESULTS

CALGARY, September 21, 2023 - Arrow Exploration Corp. (AIM: AXL; TSXV: AXL) ("Arrow" or the "Company"), the high-growth operator with a portfolio of assets across key Colombian hydrocarbon basins, is pleased to announce its AGM voting results.

Report in Respect of Voting Results Pursuant to Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations

The following sets forth a brief description of each matter voted upon at the annual general meeting (the "Meeting") of the holders of common shares of Arrow held on September 20, 2023 and the outcome of the vote:

Description of Matter

Outcome of Vote

Votes For

Votes Against or Withheld

1. Number of Directors

To set the number of directors at six (6).

Approved

81,494,609 99.64%

293,665

0.36%

2. Election of Directors

Marshall Abbott

Approved

 

81,754,333 99.96%

33,941

0.04%

Grant M. Carnie

Approved

 

81,544,778 99.70%

243,495

0.30%

Gage Jull

Approved

 

78,555,924 96.05%

3,232,349 3.95%

Ian Langley

Approved

 

81,545,205 99.70%

243,068

0.30%

Ravi Sharma

Approved

 

81,266,851 99.36%

521,422

0.64%

Anthony Zaidi

Approved

 

81,320,174 99.43%

468,099

0.57%

3. Appointment of Auditors

Appointment of Ernst & Young LLP as Auditors of the Corporation of the ensuing year and authorizing the Directors to fix their remuneration.

Approved

81,618,085 99.83%

140,188

0.17%

4. Approval and Amendment of Option Plan

To re-approve the Corporation's stock option plan and to approve certain amendments thereto as more particularly set out in the Information

Circular and Proxy Statement (collectively, the "Circular") of the Corporation dated August 8, 2023.

Approved

78,135,871 95.70%

3,514,190 4.30%

5. Approval of Option Grants to Independent Directors

To approve the grant of options to each to independent Directors of the Company

Approved

78,361,377 95.97%

3,288,684 4.03%

 

 

For further Information, contact:

Arrow Exploration

Marshall Abbott, CEO

+1 403 651 5995

Joe McFarlane, CFO

+1 403 818 1033

Brookline Public Relations, Inc.

Shauna MacDonald

 

+1 403 538 5645

 

Canaccord Genuity (Nominated Advisand Joint Broker)

Henry Fitzgerald-O'Connor

James Asensio

Gordon Hamilton

+44 (0)20 7523 8000

 

Auctus Advisors (Joint Broker)

 

Jonathan Wright (Corporate)

+44 (0)7711 627449

Rupert Holdsworth Hunt (Broking)

 

Camarco (Financial PR)

Andrew Turner

+44 (0)20 3781 8331

Rebecca Waterworth

 

Kirsty Duff

 

 

About Arrow Exploration Corp.

Arrow Exploration Corp. (operating in Colombia via a branch of its 100% owned subsidiary Carrao Energy S.A.) is a publicly traded company with a portfolio of premier Colombian oil assets that are underexploited, under-explored and offer high potential growth. The Company's business plan is to expand oil production from some of Colombia's most active basins, including the Llanos, Middle Magdalena Valley (MMV) and Putumayo Basin. The asset base is predominantly operated with high working interests, and the Brent-linked light oil pricing exposure combines with low royalties to yield attractive potential operating margins. By way of a private commercial contract with the recognized interest holder before Ecopetrol S.A., Arrow is entitled to receive 50% of the production from the Tapir block. The formal assignment to the Company is subject to Ecopetrol's consent. Arrow's seasoned team is led by a hands-on executive team supported by an experienced board. Arrow is listed on the AIM market of the London Stock Exchange and on TSX Venture Exchange under the symbol "AXL".

 

Forward-looking Statements

This news release contains certain statements disclosures relating to Arrow that are based on the expectations of its management as well as assumptions made by and information currently available to Arrow which may constitute forward-looking statements information ("forward-looking statements") under applicable securities laws. All such statements and disclosures, other than those of historical fact, which address activities, events, outcomes, results developments that Arrow anticipates expects may, occur in the future (in whole in part) should be considered forward-looking statements. In some cases, forward-looking statements can be identified by the use of the words "continue", "expect", "opportunity", "plan", "potential" and "will" and similar expressions. The forward-looking statements contained in this news release reflect several material factors and expectations and assumptions of Arrow, including without limitation, Arrow's evaluation of the impacts of COVID-19, the potential of Arrow's Colombian and/Canadian assets (any of them individually), the prices of oil and/natural gas, and Arrow's business plan to expand oil and gas production and achieve attractive potential operating margins. Arrow believes the expectations and assumptions reflected in the forward-looking statements are reasonable at this time, but no assurance can be given that these factors, expectations, and assumptions will prove to be correct.

The forward-looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results events to differ materially from those anticipated in such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company undertakes no obligations to update publicly revise any forward-looking statements, whether as a result of new information, future events otherwise, unless so required by applicable securities laws.

Neither TSX Venture Exchange nits Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility of the adequacy accuracy of this release.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGLMMTTMTMTTFJ
Date   Source Headline
29th Apr 20247:00 amRNS2023 Annual Results, MD&A and Reserves Report
2nd Apr 20245:10 pmRNSTR-1: Notification of major holdings
2nd Apr 20247:00 amRNSPDMR Exercise of Options
28th Mar 20247:00 amRNS2023 Year-End Reserves and Operations Update
20th Feb 20247:00 amRNSCN-4 and CN-5 Results
17th Jan 20247:00 amRNSOperations Update and PDMR Exercise of Options
4th Jan 20247:00 amRNSOperations Update and 2024 Guidance
29th Nov 20237:00 amRNSQ3 2023 Interim Results
16th Nov 20237:00 amRNSRCE-6 Update and Operations Update
7th Nov 20237:00 amRNSTR-1: Notification of major holdings
2nd Nov 20237:00 amRNSBlock Listing Update
26th Oct 20233:42 pmRNSTR-1: Notification of major holdings
25th Oct 20237:00 amRNSExercise of Warrants and TVR
20th Oct 202312:11 pmRNSTR-1: Notification of major holdings
19th Oct 20237:29 amRNSTR-1: Notification of major holdings
18th Oct 20233:21 pmRNSExercise of Warrants and Operations Update
18th Oct 20237:00 amRNSExercise of Warrants and Operations Update
29th Sep 20237:00 amRNSGrant Of Stock Options And TVR Update
21st Sep 20237:00 amRNSResult of AGM
18th Sep 20237:00 amRNSCN-3 Production and Production Update
11th Sep 20237:00 amRNSArrow Announces Maiden Carrizales Norte Reserves
7th Sep 20237:00 amRNSArrow Announces CN-3 Well Update
1st Sep 20237:00 amRNSTotal Voting Rights
29th Aug 20237:00 amRNSArrow Announces Q2 2023 Interim Results
21st Aug 20237:00 amRNSFiling of AGM Materials
1st Aug 20237:00 amRNSTotal Voting Rights
27th Jul 20237:05 amRNSIan Langley Appointed to Board of Directors
27th Jul 20237:00 amRNSCN-2 Well Results
25th Jul 20237:00 amRNSTR-1: Notification of major holdings
3rd Jul 20237:00 amRNSTotal Voting Rights Update
19th Jun 20237:00 amRNSCN-1 RESULTS AND OPERATIONS UPDATE
8th Jun 20237:00 amRNSCN-1 WELL UPDATE
1st Jun 20237:00 amRNSTotal Voting Rights
30th May 20237:00 amRNSCN-1 WELL UPDATE
30th May 20237:00 amRNSQ1 2023 INTERIM RESULTS
15th May 20237:00 amRNSREACHING TARGET DEPTH ON THE CN-1 WELL
9th May 20237:00 amRNSARROW ANNOUNCES BLOCKLISTING UPDATE
4th May 20237:00 amRNSSPUDDING OF CARRIZALES NORTE-1 WELL
2nd May 20237:00 amRNS2022 ANNUAL RESULTS, MD&A AND RESERVES REPORT
14th Apr 20237:00 amRNSARROW ANNOUNCES RCE-5 RESULTS & OPERATIONS UPDATE
3rd Apr 20237:00 amRNSRCE-5 Well Update
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNS2022 Year-End Reserves
24th Mar 20237:00 amRNSStandard form for notification of major holdings
22nd Mar 20237:00 amRNSRCE-4 Results and Operations Update
13th Mar 20237:00 amRNSRCE-4 Well Update
10th Mar 20237:00 amRNSARROW ANNOUNCES RESIGNATION OF DIRECTOR
3rd Mar 20237:00 amRNSRCE-3 Well Update
28th Feb 20237:00 amRNSTotal Voting Rights
21st Feb 20237:00 amRNSUpdate on RCE-3 Well and Operations Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.